Identification and characterization of GLP-1 receptor–expressing cells using a new transgenic mouse model

Richards, Paul, Parker, Helen E., Adriaenssens, Alice E., Hodgson, Joshua M., Cork, Simon C., Trapp, Stefan, Gribble, Fiona M., Reimann, Frank·2014·Diabetes

DOI 10.2337/db13-1440

Cited by (472)

Items 301–400 of 472

Myricetin Increases Circulating Adropin Level after Activation of Glucagon-like Peptide 1 (GLP-1) Receptor in Type-1 Diabetic Rats
Yingxiao Li, Kai‐Chun Cheng, I-Min Liu, Ho‐Shan Niu · 2022 · Pharmaceuticals
Depot-specific adipose tissue modulation by SGLT2 inhibitors and GLP1 agonists mediates their cardioprotective effects in metabolic disease
Nour‐Mounira Z. Bakkar, Ibrahim AlZaim, Ahmed Fawzy EL‐Yazbi · 2022 · Clinical Science
Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV
Rohani Rohani, Ellin Febrina, Indah Suasani Wahyuni, Jutti Levita · 2023 · Drug Design Development and Therapy
GLP-1-based therapies to boost autophagy in cardiometabolic patients: From experimental evidence to clinical trials
Sarah Costantino, Francesco Paneni · 2019 · Vascular Pharmacology
Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure
Thomas A. Lutz · 2016 · International Journal of Obesity Supplements
Mucosal glucagon‐like peptide 1 ( GLP ‐1) responses are mediated by calcitonin gene‐related peptide ( CGRP ) in the mouse colon and both peptide responses are area‐specific
Iain R. Tough, Runisha Moodaley, Helen M. Cox · 2017 · Neurogastroenterology & Motility
Lixisenatide requires a functional gut-vagus nerve-brain axis to trigger insulin secretion in controls and type 2 diabetic mice
Julie Charpentier, Aurélie Waget, Pascale Klopp, Chr̀istophe Magnan, Céline Cruciani‐Guglielmacci, Shin Jae Lee, Rémy Burcelin, Estelle Grasset · 2018 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice
Yeung, Martin Ho Yin, Leung, Ka Long, Choi, Lai Yuen, Yoo, Jung Sun, Yung, Susan, So, Pui-Kin, Wong, Chi-Ming · 2022 · Frontiers in Pharmacology
Networking of glucagon-like peptide-1 axons with GnRH neurons in the basal forebrain of male mice revealed by 3DISCO-based immunocytochemistry and optogenetics
Csaba Vastagh, Imre Farkas, Michael M. Scott, Zsolt Liposits · 2020 · Brain Structure and Function
Physiological and pharmacological actions of glucagon like peptide-1 (GLP-1) in domestic animals
Jorge Felipe Argenta Model, Débora Santos Rocha, Alessa da C Fagundes, Anapaula Sommer Vinagre · 2022 · Veterinary and Animal Science
Intestinal enteroendocrine L cells in amino acid sensing and diseases
Xueqin Ding · 2018 · Frontiers in bioscience
Revisiting the Diabetes-Heart Failure Connection
Markus Wallner, Deborah Eaton, Dirk von Lewinski, Harald Sourij · 2018 · Current Diabetes Reports
Simultaneous angiotensin receptor blockade and glucagon‐like peptide‐1 receptor activation ameliorate albuminuria in obese insulin‐resistant rats
Rubén Rodríguez, Benny Escobedo, Andrew Y. Lee, Max Andrew Thorwald, José A. Godoy-Lugo, Daisuke Nakano, Akira Nishiyama, David G. Parkes, Rudy Martin Ortiz · 2019 · Clinical and Experimental Pharmacology and Physiology
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
M. Riemma, E. Mele, M. Donniacuo, M. Telesca, G. Bellocchio, G. Castaldo, Francesco Rossi, A. De Angelis, D. Cappetta, K. Urbanek et al. · 2024 · Frontiers in Pharmacology
Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology
Sarina Gadgaard, Wijnand J. C. van der Velden, Sine P. Schiellerup, Jenna Elizabeth Hunt, Maria B. N. Gabe, Johanne Agerlin Windeløv, Geke Aline Boer, Hannelouise Kissow, Cathrine Ørskov, Jens Juul Holst et al. · 2021 · British Journal of Pharmacology
Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Cocaine-Mediated Behavior by Inhibiting Toll-Like Receptor 4 Signaling in Mice
Changliang Zhu, Hong Tao, Shikuo Rong, Lifei Xiao, Xinxiao Li, Shucai Jiang, Baorui Guo, Lei Wang, Jiangwei Ding, Caibing Gao et al. · 2021 · Frontiers in Pharmacology
The mediation by GLP-1 receptors of glucagon-induced insulin secretion revisited in GLP-1 receptor knockout mice
Ahrén, Bo, Yamada, Yuichiro, Seino, Yutaka · 2021 · Peptides
From Mammals to Insects: Exploring the Genetic and Neural Basis of Eating Behavior
Deepthi Mahishi, Naman Agrawal, Wenshuai Jiang, Nilay Yapici · 2024 · Annual Review of Genetics
Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
Xu He, Wei Zhao, Ping Li, Yinjiang Zhang, Guohua Li, Hongyu Su, Binan Lu, Zongran Pang · 2025 · Frontiers in Pharmacology
Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
Khaoula Errafii‬, Neyla S. Al-Akl, Olfa Khalifa, Abdelilah Arredouani · 2021 · Journal of Translational Medicine
Xanthan gum-based fluid thickener decreases postprandial blood glucose associated with increase of Glp1 and Glp1r expression in ileum and alteration of gut microbiome
Yuki Nagasawa, Sayaka Katagiri, Kazuharu Nakagawa, Tomomitsu Hirota, Kanako Yoshimi, Aritoshi Uchida, Masahiro Hatasa, Keiji Komatsu, Takahiko Shiba, Yujin Ohsugi et al. · 2022 · Journal of Functional Foods
The Enteroendocrine System in Obesity
Emily L. Miedzybrodzka, Frank M. Reimann, Fiona Mary Gribble · 2022 · Handbook of experimental pharmacology
Incretin Receptors in the Peripheral Nervous System: Implications for Obesity Treatment and Peripheral Neuropathy
Érica de Sousa, Lauren Marie Sparks, Kristy L. Townsend · 2025 · Diabetes
Efficacy of Glucagon-like Peptide-1 Receptor Agonists in Overweight/Obese and/or T2DM Adolescents: A Meta-analysis Based on Randomized Controlled Trials
Min Dai, Senjie Dai, Lihu Gu, Zhiyi Xiang, Anyi Xu, Siyu Lu, Yang Yang, Cong Zhou · 2024 · Journal of Clinical Research in Pediatric Endocrinology
Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart
Jean‐Philippe Krieger, Derek Daniels, Shin Jae Lee, Svetlana Mastitskaya, Wolfgang Langhans · 2024 · Comprehensive physiology
Nutrient sensing in the gut and the regulation of appetite
Fiona Mary Gribble, Frank M. Reimann · 2022 · Current Opinion in Endocrine and Metabolic Research
Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice
Fang‐Xin Jin, Yan Wang, Min‐Ne Li, Ru-jiang Li, Juntang Guo · 2024 · World Journal of Diabetes
Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats
Rubén Rodríguez, Meagan Moreno, Andrew Y. Lee, José A. Godoy-Lugo, Daisuke Nakano, Akira Nishiyama, David G. Parkes, Mouhamed S. Awayda, Rudy Martin Ortiz · 2018 · Hypertension Research
Tissue-Specific Expression of GLP1R in Mice: Is the Problem of Antibody Nonspecificity Solved?
Annayya Rao Aroor, Ravi Nistala · 2014 · Diabetes
Decreased expression of the GLP-1 receptor after segmental artery injury in mice
Bjørnholm, Katrine Dahl, Povlsen, Gro Klitgaard, Ougaard, Maria Elm, Pyke, Charles, Rakipovski, Günaj, Tveden-Nyborg, Pernille, Lykkesfeldt, Jens, Skovsted, Gry Freja · 2021 · Journal of Endocrinology
Hesperidin activates the GLP-1R/cAMP-CREB/IRS2/PDX1 pathway to promote transdifferentiation of islet α cells into β cells Across the spectrum
Wang Zhang, Lele Wu, Ru Qu, Tianfeng Liu, Jiliang Wang, Ying Tong, Weijian Bei, Jiao Guo, Xuguang Hu · 2024 · Heliyon
Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy
Feng Liu, Haipeng Cai · 2025 · Frontiers in Pharmacology
The role of the gut-brain axis in bariatric surgery
Tyler M. Cook, Maigen Michelle Bethea, Darleen A. Sandoval · 2025 · Current Opinion in Neurobiology
New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
Dirk von Lewinski, Ewald Kolesnik, Markus Wallner, Michael Resl, Harald Sourij · 2017 · BioMed Research International
Chronic cold stress promotes inflammation and ER stress via inhibiting GLP-1R signaling, and exacerbates the risk of ferroptosis in the liver and pancreas
Teng Teng, Yusong Zheng, Mengqi Zhang, Guodong Sun, Zhongyu Li, Baoming Shi, Tingting Shang · 2024 · Environmental Pollution
Liraglutide Preserves Intracellular Calcium Handling in Isolated Murine Myocytes Exposed to Oxidative Stress
Siripong Palee, Siriporn Chaisin Chattipakorn, Nipon Chattipakorn · 2017 · Physiological Research
Promiscuous receptor activation mediates glucagonostatic effects of GLP-1(9-36) and GLP-1(7-36)
C. Guida, C. Miranda, I. W. Asterholm, D. Basco, A. Benrick, Belén Chanclón, M. Chibalina, Matthew Harris, Joely A. Kellard, L. McCulloch et al. · 2019 · bioRxiv
GLP-1R agonist therapy and vaccine response: Neglected implications
Gustav van Niekerk, Lotte Coelmont, Yeranddy Aguiar Alpizar, Lara Kelchtermans, Elias Broeckhoven, Kai Dallmeier · 2024 · Cytokine & Growth Factor Reviews
Liraglutide ameliorates diabetic kidney disease by modulating gut microbiota and L-5-Oxoproline
Bo Yi, Ke Su, Yuli Cai, Xiaoling Chen, Yan Bao, Zhongyuan Wen · 2024 · European Journal of Pharmacology
Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction
Nóra Homoródi, Éva Varga, Zoltán Szabó, Ferenc Sztanek, Mariann Harangi · 2025 · Biomedicines
In vivo transcriptomic, functional, circuit-based, and translational analyses of enteric neurons
Claire J Millett, James J. Shaver, Bernadette Bracken, Sunny J. Jones, Robert J. Lovelett, Dave A Rubinow, R Singhal, Celia Charlton, Nadine Piazza, Quinn Hauck et al. · 2025 · Cell
Distribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract
Alice E. Adriaenssens, Frank M. Reimann, Fiona M. Gribble · 2018 · Comprehensive physiology
GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated
Muhammad Aetesam‐ur‐Rahman, Joel P. Giblett, Bharat Vashdev Khialani, Stephen J. Kyranis, Sophie J. Clarke, Tian Xiao Zhao, Denise M. Braganza, Sarah Clarke, Nick E.J. West, Martin R. Bennett et al. · 2021 · BMC Cardiovascular Disorders
PI 3‐kinase‐ and ERK‐MAPK‐dependent mechanisms underlie Glucagon‐Like Peptide‐1‐mediated activation of Sprague Dawley colonic myenteric neurons
Rebecca O'Brien, Maria M. Buckley, Amy Kelliher, Dervla O’Malley · 2019 · Neurogastroenterology & Motility
Deciphering ventricular GLP-1 action: time for a change of heart
John R. Ussher · 2014 · American Journal of Physiology-Heart and Circulatory Physiology
Gut Peptide Agonism in the Treatment of Obesity and Diabetes
Gerald Grandl, Aaron Novikoff, Richard D. DiMarchi, Matthias H. Tschöp, Timo D. Müller · 2019 · Comprehensive physiology
Pharmacokinetic and pharmacodynamic studies of supaglutide in rats and monkeys
Yijing Liao, Anran Ma, Zhihong Wang, Yue Zhou, Lin Liu, Na Zhang, Li Zhang, Gérald J. Prud’homme, Qinghua Wang · 2022 · European Journal of Pharmaceutical Sciences
Complementary and antagonistic effects of combined glucagon‐like peptide‐2 and glucagon‐like peptide‐1 receptor agonist administration on parameters relevant to short bowel syndrome
Arjuna Srikrishnaraj, Hyerin Jeong, Patricia Lee Brubaker · 2021 · Journal of Parenteral and Enteral Nutrition
New Insights into Chronic Pancreatitis: Potential Mechanisms Related to Probiotics
Yingyu Pan, Jianing Li, Zhengyang Fan, Yonghao Chen, Xiaoxuan Huang, Dong Wu · 2024 · Microorganisms
GLP-1 and IL-6 regulates obesity in the gut and brain
Kun Yang, Yuting Wu, Yan He, Jin-xiu Dai, Yu-lu Luo, Jing-hui Xie, Weijun Ding · 2024 · Life Sciences
Stat3-mTOR signaling mediates the stimulation of GLP-1 production induced by IL-27
Guoqing Lei, Linxi Chen, Miao Peng, Bolin Zeng, Qiaoxi Yang, Hening Zhai, Geyang Xu · 2019 · Journal of Molecular Endocrinology
Glucagon‐like peptide‐1 receptor differentially controls mossy cell activity across the dentate gyrus longitudinal axis
Alex Steiner, Benjamin M. Owen, James P. Bauer, Leann Seanez, Sam Kwon, Jessica E. Biddinger, Ragan Huffman, Julio E. Ayala, William P. Nobis, Alan S. Lewis · 2022 · Hippocampus
Oral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats
Pedro Henrique de Amorim Miranda, Kíssyla Christine Duarte Lacerda, Carolina Morais Araújo, José Mário Barichello, Wanderson Geraldo de Lima, Daniela Caldeira Costa · 2018 · Scientific Reports
Antiobesity medications in adult and pediatric obesity and metabolic dysfunction–associated steatotic liver disease
Natalie S. Rodriguez, Phillipp Hartmann · 2025 · Pharmacological Reviews
Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake
Martha Anna Schalla, Yvette Taché, Andreas Stengel · 2021 · Comprehensive physiology
The Expression of Glucagon-Like Peptide-1 Receptor and Dipeptidyl Peptidase-IV in Neuroendocrine Neoplasms of the Pancreas and Gastrointestinal Tract
Ryuichi Wada, Soroku Yagihashi · 2014 · Endocrine Pathology
A glycosylated Fc ‐fused glucagon‐like peptide‐1 receptor agonist exhibits equivalent glucose lowering to but fewer gastrointestinal side effects than dulaglutide
In Bok An, Mi Sun Byun, Sang In Yang, Yuri Choi, Jung Won Woo, Hak Chul Jang, Young Chul Sung · 2020 · Diabetes Obesity and Metabolism
Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide
Anita Matić, Rosemary Vuković, Marija Heffer, Marta Balog, Vedrana Ivić, Róbert Gáspár, Eszter Ducza, Kálmán Ferenc Szűcs, Adrienn B. Seres, Sandor George Vari et al. · 2021 · Croatian Medical Journal
Effects of Acute GLP-1 Infusion on Pulmonary and Systemic Hemodynamics in Patients With Heart Failure: A Pilot Study
Sophie J. Clarke, Stephen Pettit, Joel P. Giblett, Tian Xiao Zhao, Anna C. Kydd, Nicolai J. Wewer Albrechtsen, Carolyn Fiona Deacon, Jayan K. Parameshwar, Stephen Paul Hoole · 2018 · Clinical Therapeutics
Alpha-cells and therapy of diabetes: Inhibition, antagonism or death?
Natalie Klempel, Keith G. Thomas, John Michael Conlon, Peter R. Flatt, Nigel Irwin · 2022 · Peptides
Impact of short and long exposure to cafeteria diet on food intake and white adipose tissue lipolysis mediated by glucagon-like peptide 1 receptor
Pamela Mattar, Cristian Jaque, Jennifer A. Teske, Eugenia Morselli, Bredford Kerr, Vı́ctor Cortés, Rene F. Baudrand, Claudio E. Perez‐Leighton · 2023 · Frontiers in Endocrinology
Autonomic Regulation of Hepatic Glucose Production
Peter H L T Bisschop, Eric Fliers, Andries Kalsbeek · 2015 · Comprehensive physiology
Physiology and pharmacology of glucagon-like peptide-1 receptor
Д. В. Куркин, Dmitry Aleksandrovich Bakulin, Evgeny Igorevich Morkovin, Vladimir Ivanovich Petrov, Andrey V. Strygin, Ksenia N. Koryanova, Yu. V. Gorbunova, Yu. A. Kolosov, O. V. Ivanova, E. V. Pavlova et al. · 2024 · Pharmacy & Pharmacology
The Potential Mechanism of Remission in Type 2 Diabetes Mellitus After Vertical Sleeve Gastrectomy
Rongfei Wang, Salamu Mijiti, Qilin Xu, Yile Liu, Chaolun Deng, Jiangtao Huang, Abudoukeyimu Yasheng, Yunping Tian, Yanlong Cao, Yonghui Su · 2024 · Obesity Surgery
Incretin hormones and obesity
Constanza Alcaino, Frank M. Reimann, Fiona Mary Gribble · 2024 · The Journal of Physiology
The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease
Zi Guo · 2024 · Pharmacological Reports
The insulinotropic effect of exogenous glucagon‐like peptide‐1 is not affected by acute vagotomy in anaesthetized pigs
Simon Veedfald, Marie Hansen, Louise Wulff Christensen, Sara Agnete Hjort Larsen, Karina Rahr Hjøllund, Astrid Plamboeck, Bolette Hartmann, Carolyn Fiona Deacon, Jens Juul Holst · 2016 · Experimental Physiology
Luminal nutrients activate distinct patterns in submucosal and myenteric neurons in the mouse small intestine
Candice Fung, Marlene M. Hao, Yuuki Obata, Jan F. Tack, Vassilis Pachnis, Werend Boesmans, Pieter Vanden Berghe · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand effects in pancreatic β-cells and neurons
Lloyd Bridge, Shiqian Chen, Ben J. Jones · 2024 · Cellular Signalling
Comparing hypoglycemic activity of novel GPR119 agonist and DPP-4 inhibitor sitagliptin
Ivan Nikolaevich Tyurenkov, Д. В. Куркин, Dmitry Aleksandrovich Bakulin, Елена Владимировна Волотова, Mikhail Ayratovich Chafeev · 2016 · Problems of Endocrinology
May Patients Receiving GLP-1 Agonists Be at Lower Risk of Prostate Cancer Aggressiveness and Progression?
Julia Drewa, Katarzyna Lazar-Juszczak, Jan Adamowicz, Kajetan Juszczak · 2025 · Cancers
Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Spinal Fusion Outcomes: A Comprehensive Meta-Analysis
Mohamed Zahed, Mahmoud Elmesalmi, Khaled F Al-Kharouf, Sara E Elbahnasawy, Ziad El Menawy, Salam Elhanash, Mahmoud Odeh, Nour Elnaggar, Mohamed Hesham Gamal, Mahmoud M. Elhady · 2025 · Cureus
Revisiting food addiction in the era of GLP-1–based obesity pharmacotherapy via neural reward pathways linking feeding and substance use
Richard M. O’Connor · 2026 · Frontiers in Behavioral Neuroscience
GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight
Tapan Patel, Jill Rose, Kenichi Katsurada, Toshihiko Yada, Panagiotis Koutakis, Jeffrey Salomon, Kaushik P. Patel, Mabruka Alfaidi · 2026 · Circulation Research
Agonistas de GLP-1 en el control glucémico y ponderal de la diabetes tipo 2. Nuevas perspectivas
Silvia Patricia Alonso, Sergio Valdés, Viyey Kishore Doulatram‐Gamgaram · 2025 · Medicina Clínica (English Edition)
Glucagon‑like peptide‑1 receptor agonists in multiple sclerosis: therapeutic promise, challenges, and future directions
Afsaneh Shirani, Olaf Stüve · 2025 · Expert Opinion on Investigational Drugs
Antecedent hypoglycaemia impairs glucagon secretion by enhancing somatostatin-mediated negative feedback control
Rui Gao, Samuel Acreman, Haiqiang Dou, Jinfang Ma, CAROLINE A. MIRANDA, Ruiling Zhao, Matthew T. Dickerson, Andrei I. Tarasov, Qi Zou, Marta Gironella-Torrent et al. · 2026 · Nature Metabolism
Role of endogenous incretin hormones, GLP-1 and GIP, in cardiovascular physiology
Khushali Trivedi, Vernon Wayne Dolinsky · 2026 · Canadian Journal of Physiology and Pharmacology
GLP ‐1 Receptors Are Enriched in the Lymphatic Endothelium and Their Pharmacological Activation With Semaglutide Improves the Pumping Capacity of Lymphatic Vessels
Mary E. Schulz, Victoria L. Akerstrom, Joseph H. Dayan, Jorge A. Castorena‐Gonzalez · 2026 · Microcirculation
Myocardial GLP-1 Receptor Activation in the Presence of Glucose: Strong Partners
Ewald Kolesnik, Thomas Krainer, Markus Wallner, Nataša Djalinac, Nicolas Verheyen, Klemens Ablasser, Deborah Eaton, Peter P. Rainer, Brigitte Pelzmann, Dirk von Lewinski · 2018 · International Journal of Peptide Research and Therapeutics
Elucidating the central anorexigenic mechanism of glucagon-like peptide 1 in Japanese quail (Coturnix japonica)
Madison Failor, Mark Bohler, Chang Qing Cao, Elizabeth Ruth Gilbert, Mark Andrew Cline · 2023 · General and Comparative Endocrinology
Novel approaches to pharmacological management of type 2 diabetes in Japan
Shizuka Kaneko · 2021 · Expert Opinion on Pharmacotherapy
Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
Aung Myat, Satpal Singh Arri, Deepak L. Bhatt, Bernard John Gersh, Simon Robert Redwood, Michael S. Marber · 2015 · Cardiovascular Diabetology
Activation of Arcuate nucleus Glucagon-like Peptide-1 receptor-expressing neurons suppresses food intake
Ishnoor Singh, Le Wang, Baijuan Xia, Ji Liu, Azeddine Tahiri, Abdelfattah El Ouaamari, Michael B. Wheeler, Zhiping P. Pang · 2022 · Research Square
The GLP-1 analog, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice
Morgane Mermet, Jessica Denom, Aleksandra Mieczkowska, Méline Wery, Emma K. Biggs, Fiona Mary Gribble, Frank M. Reimann, Chr̀istophe Magnan, Céline Cruciani‐Guglielmacci, Guillaume Mabilleau · 2025 · American Journal of Physiology-Endocrinology and Metabolism
Glucagon-Like Peptide 1 Receptor Agonists and Cardiovascular Disease
Tatsuro Ibe, Barry A. Borlaug · 2025 · Annual Review of Medicine
From Satiety to Substance Use: Neural Mechanisms of Glucagon-Like Peptide-1 Signaling in Appetite and Reward
Caitlin Baumer-Harrison, Morgan Graham, Bart C. De Jonghe, Matthew R. Hayes · 2026 · Biological Psychiatry
In Silico Analysis of Gene Expression Location and Single Nucleotide Polymorphisms (SNPs) of The Glucagon Like Peptide 1 Receptor (GLP-1R)
Rita Maliza, Putra Santoso, Bramadi Arya, Alimuddin Tofrizal, Rarastoeti Pratiwi · 2022 · HAYATI Journal of Biosciences
Glucagon-like peptide-1 and impaired counterregulatory responses to hypoglycemia in type 1 diabetes
Gabriel Reis Rocha, Fabrício Freire de Melo · 2024 · World Journal of Diabetes
Multivalent γ‐PGA‐Exendin‐4 Conjugates to Target Pancreatic β‐Cells
Lorenzo Rossi, Krisztina Kerekes, Judit Kovács‐Kocsi, Zoltán Körhegyi, Magdolna Bodnár, Erika Fazekas, Eszter Prépost, Cataldo Pignatelli, Enrico Caneva, Francesco Nicotra et al. · 2022 · ChemBioChem
Identification of key genes and pathways revealing the central regulatory mechanism of brain-derived glucagon-like peptide-1 on obesity using bioinformatics analysis
Yu-Wei Shao, Jun Tian, Yanan Yang, Yan Hu, Ye Zhu, Qing Shu · 2022 · Frontiers in Neuroscience
EFICÁCIA E SEGURANÇA DA TIRZEPATIDA NA PREVENÇÃO DE FATORES DE RISCO CARDIOVASCULAR EM PACIENTES COM DIABETES MELLITUS TIPO 2: UMA REVISÃO SISTEMÁTICA
Maria Fernanda Gomes Rodrigues, Antônio Hítalo Mamédio Araújo, Fernanda Clara Marinheiro Oliveira, Iago Brenner Farias Leal, Izabelly Ferreira De Andrade, Milena Nunes Alves de Sousa · 2023 · Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida
The impact of GLP-1 signalling on the energy metabolism of pancreatic islet β-cells and extrapancreatic tissues
Leah A. Peart, Matthew Draper, Andrei I. Tarasov · 2024 · Peptides
Generation of iPSC lines (KAUSTi011-A, KAUSTi011-B) from a Saudi patient with epileptic encephalopathy carrying homozygous mutation in the GLP1R gene
Maryam Alowaysi, Veronica Astro, Elisabetta Fiacco, Fatema Alzahrani, Fowzan Sami Alkuraya, Antonio Adamo · 2020 · Stem Cell Research
GLP-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal?
Grazia Piras, Sara Brasili, Davide Demontis, Leonardo Della Sala, Francesco Cocchiara, Davide Carlo Maggi, Anna Arecco · 2026 · Diabetology
The Bioenergetic Architecture of Metabolic Regulation: From Gut–Brain Signalling to Next-Generation Peptide Pharmacology
Miriana Rega, Francesco Maria Petraglia, Luisa D’Ursi, Michela Buonocore, Diego Criscuolo, Angelo Santoro · 2026 · Clinical bioenergetics
Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction
Or Levi, Noam Dalal, Aviv Komissar, Daniel Moldavsky, Salma Khamaisi, Sigal Elyagon, Michael Murninkas, Adir Eliyahu, Shira Burg, Bernard Attali et al. · 2026 · EP Europace
Enteroendocrine Systems That Sense Nutrients in the Gut and Control the Body
Tohru Hira · 2022 · Journal of Nutritional Science and Vitaminology
Incretin-mediated control of cardiac energy metabolism
Jordan S. F. Chan, Tanin Shafaati, John R. Ussher · 2024 · Journal of Endocrinology
Impact of incretin-related agents on endothelial cell function
Hiroshi Nomoto, Hideaki Miyoshi, Akinobu Nakamura, Tatsuya Atsumi, Naoki Manda, Yoshio Kurihara, Shin Aoki, on behalf of SAIS Study Group · 2017 · Clinical Trials in Degenerative Diseases